MedPulse Dermatology
TOP STORIES
What the FDA's Hormone Therapy Decision Means for Aging Skin
Collaborative Project Aims to Improve Diagnosis of HS
Skin Disorders in Transgender Patients: Treatment Tips
FDA Approves First New Sunscreen Option in Two Decades
Psoriasis Workup Expanding Beyond the Skin and Joints
Drug-Induced Alopecia: When to Suspect and How to Treat It
Social Media Sunscreen Recipes Raise Safety Concerns
Most Read By Your Peers
Cosmeceutical Critique: Coconut Oil
Dermatologic Signs of Nutritional Deficiencies
FDA Approves OTC Switch for Topical Acne Treatment
Biologics Continue to Transform Psoriasis Care, Giving Physicians and Patients More Options
The Potential for Remission, Cure in Psoriasis With Biologic Treatment: A Q&A With Andrew Blauvelt, MD, MBA
NEWS
ADVERTISEMENT
Psoriasis in Pregnancy: Study Supports Safety of Biologics
Secondary Syphilis Sign Shows Reliable Histologic Pattern
Most OTC Vaginal Moisturizers Contain Contact Allergens
Golimumab Shows Benefit in Refractory HS
Psoriasis Tied to Chronic Intense Pain, Multiple Pain Sites
Bimekizumab Trumps Risankizumab in Head-to-Head PsA Trial
Takeda's AI-crafted Psoriasis Pill Tops Bristol Myers' Sotyktu in Head-to-head Trial
How Can Canada Improve Access to Dermatologic Care?
FEATURES
Pediatric Dermatology Consult: A Child With a Nontender, Nonbleeding Papule on Her Thigh
Data Trends: Sjogren Disease
FREE MEDSCAPE APP
What you need, when you need it. Available for iOS & Android.
You are receiving this newsletter because you are a registered member of Medscape. The email address associated with your membership is npocdwt4l1@niepodam.pl
Unsubscribe from MedPulse Dermatology
Opt out from all Medscape from WebMD emails
WebMD, LLC
